Description
Challenges in diagnosis and predicting disease progression in Parkinsonism.Biomarkers reflecting disease mechanisms in Parkinson's; how far have we come.
| Period | 30 Jun 2022 |
|---|---|
| Event title | 3rd meeting of society for CSF analysis and clinical Neurochemistry |
| Event type | Conference |
| Location | Berlin, GermanyShow on map |
| Degree of Recognition | International |
Keywords
- early diagnosis
- CSF biomarkers
- pathology parkinson's
- disease mechanisms
- parkinson's disease
Documents & Links
Related content
-
Research output
-
Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
Research output: Contribution to journal › Article › Academic › peer-review
-
Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson's Disease Patients and Is Present within Lewy Bodies
Research output: Contribution to journal › Article › Academic › peer-review
-
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls
Research output: Contribution to journal › Article › Academic › peer-review
-
α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
Research output: Contribution to journal › Article › Academic › peer-review
-
CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson's Disease
Research output: Contribution to journal › Article › Academic › peer-review
-
Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies
Research output: Contribution to journal › Article › Academic › peer-review